Climb Bio, Inc. (CLYM)
10.29
+1.42
(+16.01%)
USD |
NASDAQ |
Nov 06, 16:00
10.25
-0.04
(-0.39%)
After-Hours: 20:00
Climb Bio Total Long Term Debt (Quarterly) : 0.605M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.605M |
| June 30, 2026 | 0.813M |
| March 31, 2026 | 0.216M |
| December 31, 2025 | 0.285M |
| September 30, 2025 | 0.352M |
| June 30, 2025 | 0.417M |
| March 31, 2025 | 0.319M |
| December 31, 2024 | 0.375M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.015M |
| September 30, 2023 | 0.058M |
| Date | Value |
|---|---|
| June 30, 2023 | 0.10M |
| March 31, 2023 | 0.223M |
| December 31, 2022 | 0.18M |
| September 30, 2022 | 0.219M |
| June 30, 2022 | 0.256M |
| March 31, 2022 | 0.381M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 0.984M |
| Cullinan Therapeutics, Inc. | 1.405M |
| Q32 Bio, Inc. | 4.364M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |